This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 29 Dec 2015  |  Global

    Collaboration between Medical Devices, Pharmaceuticals, and Biotechnology

    Strategic Partnerships that are Transforming the Healthcare Industry

    In an increasingly convergent industry such as healthcare, business collaborations are not only a necessity, but an inevitability. It is interesting to note that technologies and market segments that receive the most funding and research focus, are also the areas that are ripe for collaborative partnerships. Market segments such as personalized med...

    $4,950.00
  2. 30 Sep 2015  |  Europe

    Advanced mechanisms in drug delivery

    Impact and assessment of modern mechanisms in drug delivery systems

    The research service aims to give a global outlook of the companion diagnostic market landscape, with a specific focus on Western European countries. The segments related to oncology discussed in this study include breast cancer, lung cancer, colorectal cancer and other cancers, and non-oncology related infectious disease, CNS, and cardiovascular. ...

    $4,950.00
  3. Monoclonal antibody therapeutics are being used for treatment of a wide array of diseases, specially in therapeutic areas such as oncology, immunology (including autoimmune and inflammatory diseases, as well as, transplant rejection) and neuroscience. The development of these new molecular agents, successfully directed to specific cellular targets,...

    $4,950.00
  4. 29 Sep 2015  |  Global

    Transforming cancer treatment with Immunotherapy (TechVision)

    Fight cancer with Immunotherapy

    This research service focuses on the current status of candidates for opioid therapeutics with a focus on current Phase 3 candidates, detailed timelines, rational for pivotal program design, Phase 2 data review and key opinion leader (KOL) commentary. A pipeline assessment is provided for all active candidates in development. The information contai...

    $4,950.00
  5. 29 Jun 2015  |  Global

    Trends in mammalian cell cultures

    Technology Market Penetration and Roadmapping

    With the growing need for better therapeutics, and the current patent cliff that is underway, therapies such as monoclonal antibodies, recombinant protein therapeutics and even vaccines for a whole host of indications are in high demand. Conventionally expression systems were utilized to aid in the development and production of these therapeutics...

    $4,950.00
  6. 07 May 2015  |  Global

    Top Health and Wellness Technologies in 2015 (Technical Insights)

    Healthcare Technologies of the Future

    Technical Insights division of Frost & Sullivan evaluated technology trends in the Health and Wellness sector and has identified top technology trends that are likely to have an impact in the year 2015. The research service provides an in depth analysis of the top 10 health and wellness technologies that are anticipated to have the highest impact a...

    $4,950.00
  7. 31 Mar 2015  |  Global

    Trends in Preventative Healthcare (Technical Insights)

    Impact and assessment of key innovations in preventive healthcare

    Preventative healthcare, or preventive healthcare, accounts for measures that are adopted for disease prevention rather than disease treatment. Millions of people die preventable deaths every year and this can be due to environmental factors, lifestyle choices, and genetic susceptibility. Leading causes for the majority of preventable deaths includ...

    $3,950.00
  8. 29 Dec 2014  |  Global

    Emerging Trends in Cell Banking (Technical Insights)

    Trends in Master and Working Cell Baking

    The execution of different test methods aiming to evaluate the stability and potency of biopharmaceutical products, as well as, their pharmacokinetic/pharmacodynamic (PK/PD) profiles, their characterization and comparison with other drugs, or the detection of antidrug antibodies (ADAs) or neutralizing antibodies (NAB), represent critical stages in ...

    $3,950.00
  9. 27 Jun 2014  |  Global

    Stem Cells -- 6 Dimensional Assessment (Technical Insights)

    The clinical translation of regenerative cells

    The scope of this research service comprises research within the area of adult and embryonic stem cells, and developments in the nascent area of induced pluripotent stem cells. While it will be next to impossible to capture all the developments in this area, this research service profiles some global developments in the area of stem cells. Popular ...

    $4,950.00
  10. The future of healthcare is moving towards become more personalized. An individuals genetic information is become a crucial component to assess the risks and predispositions one has towards acquiring a while host of indications. Embracing genetic best tests, will help world economies by reducing the millions of dollars spent in present diagnostic a...

    $4,950.00